Skip to main content
. 2023 Aug 23;4(4):353–360. doi: 10.1016/j.xfre.2023.08.006

Table 2.

Clinical activities performed by GCs who counseled about mosaic embryos in preimplantation and prenatal settings.

Activities included in role (yes) N (%)
GCs who counseled in preimplantation settings 64
Provided pretest counseling for PGT-A 32 (51)
Provided posttest counseling after PGT-A 55 (87)
 Disclosed PGT-A results, including mosaic findings 25 (46)
 Interpreted PGT-A results, including mosaic findings 42 (76)
 Discussed possible pregnancy outcomes of MET on the basis of PGT-A results 55 (100)
 Facilitated patients’ decision-making (i.e., to consider MET, cryopreserve or discard embryos, and/or undergo another IVF cycle) 45 (82)
 Helped rank mosaic embryos for transfer on the basis of specific PGT-A results 35 (64)
 Discussed prenatal screening and prenatal diagnosis options 53 (96)
 Facilitated referral to a prenatal genetics clinic 15 (27)
 Discussed postnatal assessment 26 (47)
GCs who counseled in prenatal settings 47
Counseled about possible pregnancy outcomes after MET 43 (92)
Testing options GCs recommended to patients pregnant after MET
 Amniocentesis 40 (85)
 Chorionic villus sampling 6 (13)
 NIPT 7 (15)
 Postnatal assessment 23 (49)
 Other 4 (9)

GC = genetic counselor; IVF = in vitro fertilization; MET = mosaic embryo transfer; NIPT = noninvasive prenatal testing; PGT-A = preimplantation genetic testing for aneuploidy.